Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Chelsea Nimmo
ID:
1b839946-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
14 articles
Higher costs awards coming to the Federal Court, including for pharma regulatory and IP disputes
Pharma in Brief ·
February 26, 2023
cite
Governmental Use of Patented Inventions during a Pandemic: A Global Survey
Pharma in Brief ·
April 22, 2020
cite
New Federal initiatives to combat pandemic: Patent Act amended to allow limited government use of patented inventions for public health emergencies
Pharma in Brief ·
March 25, 2020
cite
Two generics, one hearing: Federal Court orders common trial on patent validity issues in section 6 actions
Pharma in Brief ·
November 22, 2018
cite
First motion for early patent dismissal fails to meet high burden under newly-amended PM(NOC) Regulations
Pharma in Brief ·
July 30, 2018
cite
Previous
1
2
3
Next
Practice Areas
Health Care and Life Sciences
Jurisdictions
Canada
North America
